Overview A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression Status: Completed Trial end date: 2020-05-10 Target enrollment: Participant gender: Summary This study will evaluate the Safety, Pharmacokinetics and Efficacy of IV Administration of Ganaxolone in Women with Postpartum Depression Phase: Phase 2 Details Lead Sponsor: Marinus PharmaceuticalsTreatments: GanaxolonePregnanolone